MG Shlipak - Annals of internal medicine, 2003 - Am Coll Physicians Clinical trials have demonstrated that angiotensin-converting enzyme (ACE)
inhibitors, β-blockers, and spironolactone improve survival in patients with
heart failure. Because patients with heart failure and renal insufficiency ... Cited by 118 - Related articles - BL Direct - All 6 versions
ACE Inhibitors - Ann Intern Med, 2003 - palliative.uab.edu Clinical trials have demonstrated that angiotensin-converting en- zyme (ACE)
inhibitors, -blockers, and spironolactone improve survival in patients with
heart failure. Because patients with heart failure and renal insufficiency ... Related articles - View as HTML - All 4 versions
- ►ahajournals.org MG Shlipak, BM Massie - Circulation, 2004 - Am Heart Assoc Renal dysfunction is a common and progressive complication of chronic heart
failure, with a clinical course that typically fluctuates with the patient's
clinical status and treatment. Despite growing recognition of the frequent ... Cited by 77 - Related articles - BL Direct - All 7 versions
- ►asnjournals.org MG Shlipak, GL Smith, SS Rathore, BM … - Journal of the American Society of Nephrology, 2004 - Am Soc Nephrol ABSTRACT. Renal dysfunction is a common complication for patients with heart
failure, but its association with clinical outcomes has not been fully
characterized. We evaluated the association of glomerular filtration rate ... Cited by 67 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org [PDF] K Bibbins-Domingo, F Lin, E Vittinghoff, E … - Journal of the American College of Cardiology, 2004 - Elsevier This prospective cohort study retrospectively analyzed data from the Heart and
Estrogen/progestin Replacement Study (HERS). Of the 2,763 women in HERS, 702 had
HF. Renal function was categorized as creatinine clearance (CrCl) >60 ... Cited by 50 - Related articles - BL Direct - All 14 versions
- ►ahajournals.org FA McAlister, J Ezekowitz, M Tonelli, PW … - Circulation, 2004 - Am Heart Assoc Methods and Results— We analyzed data from a prospective cohort of 754
patients with heart failure who had ejection fraction, serum creatinine, and
weight measured at baseline. Median age was 69 years, and 43% had an ... Cited by 229 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org HL Hillege, ARJ Girbes, PJ de Kam, F … - Circulation, 2000 - Am Heart Assoc Methods and Results—The study population consisted of 1906 patients with CHF
who were enrolled in a recent survival trial (Second Prospective Randomized
study of Ibopamine on Mortality and Efficacy). In a subgroup of 372 ... Cited by 488 - Related articles - BL Direct - All 10 versions
- ►oxfordjournals.org LG Bongartz, MJ Cramer, PA Doevendans, JA … - European heart journal, 2005 - Eur Soc Cardiology The incidence of cardiac failure and chronic renal failure is increasing and it
has now become clear that the co-existence of the two problems has an extremely
bad prognosis. We propose the severe cardiorenal syndrome (SCRS), a ... Cited by 99 - Related articles - All 8 versions
- ►onlinejacc.org J Ezekowitz, FA McAlister, KH Humphries, CM … - Journal of the American College of Cardiology, 2004 - Elsevier Renal insufficiency is associated with poorer outcomes in patients with HF, but
the mechanisms are uncertain. In particular, the degree of therapeutic nihilism
in these patients, and whether it is appropriate, is unclear. Cited by 89 - Related articles - BL Direct - All 10 versions
S Ljungman, J Kjekshus, K Swedberg - The American journal of cardiology, 1992 - Elsevier The effect on renal function of long-term treatment with either enalapril (n =
123) or placebo (n = 120) in addition to conventional therapy was studied in a
randomized trial in patients with severe congestive heart failure (New York ... Cited by 95 - Related articles - All 3 versions
